Market Cap 2.73B
Revenue (ttm) 258.00M
Net Income (ttm) -283.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -109.69%
Debt to Equity Ratio 0.22
Volume 1,275,400
Avg Vol 1,689,032
Day's Range N/A - N/A
Shares Out 107.97M
Stochastic %K 79%
Beta 0.75
Analysts Strong Sell
Price Target $35.10

Company Profile

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; and Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 694 6200
Address:
3928 Point Eden Way, Hayward, United States
Ventureville
Ventureville Dec. 5 at 4:40 PM
$BIOV.CSE DPX validation puts this stock on similar ground as $ANIX, $RCUS, and other immuno plays that ran 80-300% this year.
0 · Reply
Davidendz
Davidendz Dec. 4 at 9:45 PM
Sector ripping: $RCUS +110%, $ANIX +80%, $IOVA flying. $BIOV DPX data just dropped fire. Next in line.
0 · Reply
MRTunity
MRTunity Dec. 3 at 4:00 PM
$RCUS contemplating buying back my 1/3! 🤔 Nice recovery off $25 and back into this bull flag , $XBI seems to have bounced off a higher low and back above 120+ Can basically rebuy where I sold which is a win
1 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:29 PM
Morgan Stanley updates rating for Arcus Biosciences ( $RCUS ) to Overweight, target set at 25 → 24.
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:27 PM
Morgan Stanley has adjusted their stance on Arcus Biosciences ( $RCUS ), setting the rating to Overweight with a target price of 22 → 23.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 4:46 PM
$RBRK $RCAT $RCUS $RDDT $RDNT Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥
0 · Reply
AAUS1
AAUS1 Dec. 2 at 3:11 PM
$RCUS Good idea to buy before so called 5 star rated analysts upgrade this stock, their vision is only 3 months anyway !!
0 · Reply
Bobes
Bobes Dec. 2 at 3:17 AM
$RCUS if gild pays 55 bucks a share it would cost them roughly 4.7b. That is 55×140m gets you to 7.7b. They own 25% so now down to 5.7b. Now they get the 1b in cash. That gets you to 4.7b. Sounds high but cas is a 2b a year drug so the average deal is 3.4x peak. So thats 6.8b. They get the half of tigit they dont own plus everything else in the pipe. Now 4.7b sounds like a deal. Used 140m shares as the fully diluted basis but could be more. Too lazy to look up
1 · Reply
MRTunity
MRTunity Dec. 1 at 8:47 PM
$RCUS Strong Like Bull 🐂 💪 $XBI -2.5%+ and still can’t hold Arcus down 🔥
0 · Reply
AAUS1
AAUS1 Dec. 1 at 4:20 PM
0 · Reply
Latest News on RCUS
Arcus Biosciences Announces New Employment Inducement Grants

Oct 9, 2025, 4:35 PM EDT - 2 months ago

Arcus Biosciences Announces New Employment Inducement Grants


Why Is Arcus Biosciences Stock Trading Higher On Monday?

Oct 6, 2025, 2:23 PM EDT - 2 months ago

Why Is Arcus Biosciences Stock Trading Higher On Monday?


Arcus (RCUS) Q2 Revenue Jumps 310%

Aug 6, 2025, 11:05 PM EDT - 4 months ago

Arcus (RCUS) Q2 Revenue Jumps 310%


Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call Transcript

May 6, 2025, 8:17 PM EDT - 7 months ago

Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call Transcript


Arcus: Excellent Pipeline And Collaborations, Cash Runway

Jan 13, 2025, 8:00 AM EST - 11 months ago

Arcus: Excellent Pipeline And Collaborations, Cash Runway


Ventureville
Ventureville Dec. 5 at 4:40 PM
$BIOV.CSE DPX validation puts this stock on similar ground as $ANIX, $RCUS, and other immuno plays that ran 80-300% this year.
0 · Reply
Davidendz
Davidendz Dec. 4 at 9:45 PM
Sector ripping: $RCUS +110%, $ANIX +80%, $IOVA flying. $BIOV DPX data just dropped fire. Next in line.
0 · Reply
MRTunity
MRTunity Dec. 3 at 4:00 PM
$RCUS contemplating buying back my 1/3! 🤔 Nice recovery off $25 and back into this bull flag , $XBI seems to have bounced off a higher low and back above 120+ Can basically rebuy where I sold which is a win
1 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:29 PM
Morgan Stanley updates rating for Arcus Biosciences ( $RCUS ) to Overweight, target set at 25 → 24.
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:27 PM
Morgan Stanley has adjusted their stance on Arcus Biosciences ( $RCUS ), setting the rating to Overweight with a target price of 22 → 23.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 4:46 PM
$RBRK $RCAT $RCUS $RDDT $RDNT Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥
0 · Reply
AAUS1
AAUS1 Dec. 2 at 3:11 PM
$RCUS Good idea to buy before so called 5 star rated analysts upgrade this stock, their vision is only 3 months anyway !!
0 · Reply
Bobes
Bobes Dec. 2 at 3:17 AM
$RCUS if gild pays 55 bucks a share it would cost them roughly 4.7b. That is 55×140m gets you to 7.7b. They own 25% so now down to 5.7b. Now they get the 1b in cash. That gets you to 4.7b. Sounds high but cas is a 2b a year drug so the average deal is 3.4x peak. So thats 6.8b. They get the half of tigit they dont own plus everything else in the pipe. Now 4.7b sounds like a deal. Used 140m shares as the fully diluted basis but could be more. Too lazy to look up
1 · Reply
MRTunity
MRTunity Dec. 1 at 8:47 PM
$RCUS Strong Like Bull 🐂 💪 $XBI -2.5%+ and still can’t hold Arcus down 🔥
0 · Reply
AAUS1
AAUS1 Dec. 1 at 4:20 PM
0 · Reply
Bobes
Bobes Nov. 29 at 8:48 PM
$RCUS we hit 1800 watchers.... now just 44k more to hit auph levels... i think number 1800 was Terry.
1 · Reply
eriklarsen
eriklarsen Nov. 28 at 7:17 PM
$RCUS We all know there are no real drivers until phase 3 TIGIT read. That's literally a year from now, at the earliest. So why the price move? I don't want to fuel BO speculations but it seems to be the best explanation.
1 · Reply
anachartanalyst
anachartanalyst Nov. 28 at 6:01 PM
$RCUS https://anachart.com/wp-content/uploads/ana_temp/1764352889_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Nov. 28 at 5:04 PM
B of A Securities has updated their rating for Arcus Biosciences ( $RCUS ) to Neutral with a price target of 26.
0 · Reply
MRTunity
MRTunity Nov. 28 at 4:12 PM
$RCUS going to chop 1/3 here today at $26+ 💪 Up big from $8.594 avg 🙏 Greatly reducing portion of my positions across the board , and raising cash 💵 I’m sure RCUS AUPH or TGTX will get a buyout offer come Monday because I’m doing this lol I BELIEVE WE COULD BE SEEING A $35-$50 BO OFFER so keeping 2/3 my position given this stock just keeps hitting “Higher Highs” + Higher Lows ‼️
0 · Reply
AAUS1
AAUS1 Nov. 28 at 3:38 PM
$RCUS Better to buy before Dec 3rd
0 · Reply
DonCorleone77
DonCorleone77 Nov. 28 at 2:00 PM
$GOOGL $RCUS $CNH $TLRY $DE PRE-MARKET MOVERS: Currently Higher: - Alphabet (GOOGL) up 1.3% leading gains among Magnificent Seven stocks as technology shares edge higher - Arcus Biosciences (RCUS) up 1.3% after Bank of America upped their price target to $26 from $17. Currently Lower: - CNH Industrial (CNH) - down 1.1% after JPMorgan cut its recommendation on the shares to Underweight, citing an agricultural equipment industry outlook from Deere (DE) - Tilray Brands (TLRY) - down 13.6% after the cannabis company announced that it will implement a one-for-ten reverse stock split
0 · Reply
RNASequencing
RNASequencing Nov. 28 at 2:46 AM
$RCUS very strong relative strength since raise small position. Congrats to the longs
0 · Reply
Randy2979
Randy2979 Nov. 27 at 3:36 PM
$RCUS @TheGunnerAB I would like to thank you for posting about this stock on the auph feed that made me do my research/DD and go heavy here from April through June. This is only stock in my portfolio and I hit the 6 figure mark in unrealized profit this week. Happy Thanksgiving !
1 · Reply
ChartistMoM
ChartistMoM Nov. 27 at 2:59 PM
$TGTX It's Thanksgiving at the Chartist household, but things are a little somber. My 7th husband has left us, and now I'm stuck with my sister who I don't like, 2 ex-husbands that decided to invite themselves, and my son "Chartist." Just the 5 of us. My son had a bad week. He was convinced that his short positions in TGTX and $RCUS would work, but now he's a ruined little boy. His margin calls had to be met, and I had to wire what I had left in my savings to Mr. Schwab to cover it. Flat out broke here. But I was insistent on having Thanksgiving. So, we're doing Thanksgiving "budget style" at the Chartist compound (900 sq. ft home) tonight. I bought 5 Cornish Hens, 2 Caesar salad kits, and some stuffing mix. Just got done prepping the Cornish hens. Cleaned them and stuffed them with stuffing. I gotta tell ya, it's hard to get stuffing in those little buggers. Delish! Despite the margin calls and abject failure of my son to read charts... we're still gonna have Thanksgiving. Love, mom.
3 · Reply
ACES_
ACES_ Nov. 27 at 3:36 AM
$RCUS I would not be shocked if it was this year...
1 · Reply
Randy2979
Randy2979 Nov. 26 at 7:45 PM
0 · Reply